Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals

Details for Australian Patent Application No. 2003251466 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Wohlfart, Paulus; Strobel, Hartmut

Agent Watermark

Pub. Number AU-B-2003251466

PCT Number PCT/EP03/08103

PCT Pub. Number WO2004/014372

Priority 02017586.5 07.08.02 EP

Filing date 24 July 2003

Wipo publication date 25 February 2004

Acceptance publication date 23 April 2009

International Classifications

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4184 (2006.01)

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4436 (2006.01)

A61K 31/444 (2006.01)

A61K 31/497 (2006.01)

A61K 31/5377 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 221/04 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 333/78 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02017586.5 07.08.02 EP

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003251466

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

23 April 2009 Application Accepted

  Published as AU-B-2003251466

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251467-DEVICE FOR PRODUCING MOULDED BRICKS

2003251465-CONTINUOUS METHOD FOR THE PRODUCTION OF CARBONYL COMPOUNDS